Page 130 - HIVMED_v21_i1.indb
P. 130

Southern African Journal of HIV Medicine
              ISSN: (Online) 2078-6751, (Print) 1608-9693
                                                       Page 1 of 3  Scientific Letter


               Antiretroviral therapy under the wing of the COVID-19

                         epidemic: One look, and different solutions






               Authors:                Introduction
               Heba Elsayed   1
               Mohamed Hassany         Dear editors, we read with great interest the editorial ‘Antiretroviral therapy optimization in the
                           2,3
                                                                                                         1
                                       time of COVID-19: Is it really different in North and South Africa?’ by Cordie et al.  and we find
               Affiliations:           it an excellent opportunity to address some critical issues.
               1 National AIDS Program,
               Ministry of Health and
               Population, Cairo, Egypt  With the detection of the first case of the human immunodeficiency virus (HIV) in Egypt in
                                       1986, the Ministry of Health and Population (MOHP) established the National AIDS Program
               2 Tropical Medicine     (NAP) as the entity responsible for combating the HIV epidemic in the country. This task has
               Department, National    included prevention and the care and treatment of people living with HIV (PLHIV) and
               Hepatology and Tropical   coordinating the efforts of stakeholders such as the United Nations (UN) and civil society
               Medicine Research Institute,
               Cairo, Egypt            organizations (CSOs). 2

               3 Ministry of Health and   Antiretroviral therapy procurement strategies in Egypt
               Population, Cairo, Egypt
                                       Antiretroviral (ARV) drugs were first introduced in Egypt in 2008. From 2008 to 2014, these were
               Corresponding author:   funded from the Global Fund to Fight AIDS, tuberculosis and malaria (GFATM). In 2014, the
               Mohamed Hassany,
               mohamadhassany@         MOHP took the step to start covering ARV drugs from domestic funding and succeeded from
               yahoo.com               2017 until now to cover 100% of Egypt’s needs from the domestic funds. This has been with a view
                                       to ensure ARV-sustainability and avoid the risk of stockouts. This is considered a unique initiative
               Dates:                  amongst all countries in the region.  Egypt has given attention to the procurement and supply
                                                                    3,4
               Received: 06 Sept. 2020
               Accepted: 02 Oct. 2020  management of ART. Clinic pharmacists were provided with a comprehensive medication policy
               Published: 15 Dec. 2020  and capacity-building  standards through international  experts. The latter were recruited by
                                       UNICEF, the agency that assists the government in the procurement of unregistered ARVs. This
               How to cite this article:  provides ART clinics with a unique stock management system.  In 2018, the MOHP encouraged
                                                                                         5
               Elsayed H, Hassany M.
               Antiretroviral therapy under   local pharmaceutical companies to register all first-line ARVs. This covers approximately 97% of
               the wing of the COVID-19   the drugs needed by PLHIV. The remaining unregistered ARVs are procured via UNICEF. 5
               epidemic: One look, and
               different solutions. S Afr J HIV
               Med. 2020;21(1), a1167.   National treatment policies and recommendations
               https://doi.org/10.4102/  National AIDS Program has expanded the treatment options for PLHIV in accordance with the
               sajhivmed.v21i1.1167
                                       World Health Organization’s (WHO’s) guidelines and the national context. The most recent
               Copyright:              Egyptian National Care and ARVs Guidelines were published in 2015. These were followed in
               © 2020. The Authors.    2017 by a summary update. This adopted a ‘Test and Treat/Treat All’ approach that supplies
               Licensee: AOSIS. This work
               is licensed under the   ARVs to all PLHIV regardless of their CD4 count or viral load level. This update included the
               Creative Commons        introduction of dolutegravir (DTG) as an alternative first-line option to efavirenz (EFV) as per
               Attribution License.    the WHO recommendations. 6

                                       Tenofovir disoproxil fumarate + emtricitabine (TDF + FTC) is the preferred nucleoside
                                       reverse-transcriptase inhibitor (NRTI) first-line ART backbone. As per our National guidelines,
                                       TDF + FTC + EFV is the currently preferred first-line regimen. An alternative NRTI backbone is the
                                       combination of zidovudine (AZT) and 3TC, which is registered and manufactured locally. 7

                                       The global effect of coronavirus disease on medication
                                       supply chain

                                       With the evolution of the coronavirus disease 2019 (COVID-19) pandemic, all countries have taken
               Read online:            measures to control the spread of the infection. As a result of the lockdown and the interference with
               Read online:
                        Scan this QR
                        Scan this QR   international  flights,  global  health  systems  have  faced  the  potential  of  medicine  stock-outs.
                        code with your                                                8
                        code with your
                        smart phone or
                        smart phone or   Seventy-three countries reported such a risk of ARV stockouts.  Based on a recent UNAIDS study that
                        mobile device   explores challenges facing global HIV programmes, reduced production and availability of active
                        mobile device
                        to read online.
                        to read online.
                                       pharmaceutical ingredients (APIs) and issues with transportation have negatively affected dependent
                                           http://www.sajhivmed.org.za 122  Open Access
   125   126   127   128   129   130   131   132   133   134   135